Next, we examined the level of a well-known cancer stem cell (CSC) marker CD44 mRNA by qRT-PCR in chemoresistant (n = 13) and sensitive (n = 11) HNSCC patients’ samples. The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.